AIB1 is a predictive factor for tamoxifen response in premenopausal women. (Q45921492)

17 December 2017

title

AIB1 is a predictive factor for tamoxifen response in premenopausal women. (English)

1 reference

17 December 2017

1 reference

S Alkner

1

1 reference

17 December 2017

P-O Bendahl

2

1 reference

17 December 2017

D Grabau

3

1 reference

17 December 2017

K Lövgren

4

1 reference

17 December 2017

O Stål

5

1 reference

17 December 2017

L Rydén

6

1 reference

17 December 2017

M Fernö

7

1 reference

17 December 2017

Swedish and South-East Swedish Breast Cancer Groups

8

1 reference

17 December 2017

publication date

23 July 2009

1 reference

17 December 2017

published in

Annals of Oncology

1 reference

17 December 2017

volume

21

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

238-244

1 reference

17 December 2017

Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

Ribozyme targeting demonstrates that the nuclear receptor coactivator AIB1 is a rate-limiting factor for estrogen-dependent growth of human MCF-7 breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

SRC-3/AIB1: transcriptional coactivator in oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP293

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDP293

1 reference

17 December 2017

PubMed ID

19628566

1 reference

17 December 2017